Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Nanomedicine

Barcodes check out prostate cancer

An assay based on gold nanoparticles could detect recurrences of prostate cancer sooner than is possible with existing techniques.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A bio-barcode assay for prostate specific antigen.

References

  1. Freedland, S. J. & Moul, J. W. J. Urol. 177, 1985–1991 (2007).

    Article  Google Scholar 

  2. Thaxton, C. S. et al. Proc. Natl Acad. Sci. USA 106, 18437–18442 (2009).

    Article  CAS  Google Scholar 

  3. Barry, M. J. N. Engl. J. Med. 360, 1351–1354 (2009).

    Article  CAS  Google Scholar 

  4. Healy, D. A. et al. Trends Biotechnol. 25, 125–131 (2007).

    Article  CAS  Google Scholar 

  5. Thompson, I. M. et al. J. Natl Cancer Inst. 98, 529–534 (2006).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hearty, S., Leonard, P. & O'Kennedy, R. Barcodes check out prostate cancer. Nature Nanotech 5, 9–10 (2010). https://doi.org/10.1038/nnano.2009.459

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2009.459

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing